News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Breast Cancer Briefing

Sara Nunnery, MD, MSCI, breast medical oncologist, director, Breast Cancer Research, Tennessee Oncology; Annie Bond, breast cancer survivor, patient advocate

Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond

BySara Nunnery, MD, MSCI,Annie Bond

May 12th 2026

Dr Nunnery and Annie Bond discuss breast cancer survivorship and patient advocacy.

Sara Nunnery, MD, MSCI, Tennessee Oncology; Irene Morae Kang, MD, City of Hope Orange County

ADCs Change Treatment Paradigms and Challenge Standard AE Management Protocols in TNBC: With Sara Nunnery, MD, MSCI; and Irene Morae Kang, MD

BySara Nunnery, MD, MSCI,Irene Morae Kang, MD

April 30th 2026

Drs Nunnery and Kang discuss the rapidly evolving treatment paradigm for first-line metastatic TNBC, including the emergence of novel ADCs.

Sara Nunnery, MD, MSCI, breast medical oncologist, director, Breast Cancer Research, Tennessee Oncology in Nashville; Neil M. Iyengar, MD, associate professor, co-director, Breast Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine, director, Survivorship Services, Winship Cancer Institute of Emory University

Evolving Research Puts a Focus on GLP-1 Agonist Use in Breast Cancer: With Sara Nunnery, MD, MSCI; and Neil M. Iyengar, MD

BySara Nunnery, MD, MSCI,Neil Iyengar, MD

April 16th 2026

Drs Nunnery and Iyengar highlight the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

Sara Nunnery, MD, MSCI, breast medical oncologist, director, Breast Cancer Research, Tennessee Oncology in Nashville; Neil M. Iyengar, MD, associate professor, co-director, Breast Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine, director, Survivorship Services, Winship Cancer Institute of Emory University

Lifestyle Interventions, Exercise Programs, and Metabolic Medications Are Key to Holistic Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Neil M. Iyengar, MD

BySara Nunnery, MD, MSCI,Neil Iyengar, MD

April 2nd 2026

Drs Nunnery and Iyengar discuss lifestyle and medical interventions pertinent to breast cancer survivorship.

Kelly E. McCann, MD, PhD, breast medical oncologist, University of California system; Sara Nunnery, MD, MSCI, breast medical oncologist, Tennessee Oncology

T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

BySara Nunnery, MD, MSCI,Kelly E. McCann, MD, PhD

March 26th 2026

Drs Nunnery and McCann discuss the evolving HER2-positive breast cancer treatment paradigm.

Trending on OncLive

Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings

Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026

Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer

Sonrotoclax Plus Zanubrutinib Yields High Undetectable MRD Rates in Treatment-Naive CLL/SLL

FDA Grants Priority Review to Adjuvant Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer